跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,813 条关于
“Lynk Labs”
全部
1,813
临床试验
632
药物
251
机构
155
资讯
775
12个月前
Lynk Labs Challenges Federal Circuit's Patent Prior Art Interpretation in Supreme Court Petition
9个月前
Lynk Pharmaceuticals Receives FDA IND Approval for Brain-Penetrant TYK2 Inhibitor LNK01006 Targeting Neuroinflammatory Diseases
8个月前
Lynk Pharmaceuticals Reports Positive Phase III Results for Zemprocitinib in Rheumatoid Arthritis
10个月前
Lynk Pharmaceuticals' Topical JAK Inhibitor LNK01004 Shows Promising Phase II Results for Moderate-to-Severe Atopic Dermatitis
3个月前
Formation Bio Doses First Participant in Phase 1 Trial of CNS-Penetrant TYK2 Inhibitor BLKR201
去年
Biomind Labs Highlights Growing U.S. Support for Psychedelic Therapies
去年
Waters Acquires Halo Labs to Enhance Biologic Therapy Analysis Capabilities
去年
Leyden Labs Secures $70 Million to Advance Intranasal Antibody Therapies Against Respiratory Viruses
2个月前
Latent Labs Launches Latent-Y, First Lab-Validated AI Drug Design Agent, to Researchers Worldwide
去年
Neurovation Labs Secures Patent for Novel PTSD Biomarker Detection Technology
第 1 页,共 78 页
上一页
下一页